Literature DB >> 16257247

Novel properties of malarial S-adenosylmethionine decarboxylase as revealed by structural modelling.

Gordon A Wells1, Lyn-Marie Birkholtz, Fourie Joubert, Rolf D Walter, Abraham I Louw.   

Abstract

In the malaria parasite, the two main regulatory activities of polyamine biosynthesis, ornithine decarboxylase (ODC) and S-adenosylmethionine decarboxylase (AdoMetDC) occur in a single bifunctional protein. The AdoMetDC domain was modeled using the human and potato X-ray crystal structures as templates. Three parasite-specific inserts and the core active site region was identified using a structure-based alignment approach. The domain was modeled without the two largest inserts, to give a root mean square deviation of 1.85 angstroms from the human template. Contact with the rest of the bifunctional complex is predicted to occur on one face of the Plasmodium falciparum AdoMetDC (PfAdoMetDC) domain. In the active site there are four substitutions compared to the human template. One of these substitutions may be responsible for the lack of inhibition by Tris, compared to mammalian AdoMetDC. The model also provides an explanation for the lack of putrescine stimulation in PfAdoMetDC compared to mammalian AdoMetDC. A network of residues that connects the putrescine-binding site with the active site in human AdoMetDC is conserved in the malarial and plant cognates. Internal basic residues are found to assume the role of putrescine, based on the model and site-directed mutagenesis: Arg11 is absolutely required for normal activity, while disrupting Lys15 and Lys215 each cause 50% inhibition of AdoMetDC activity. These novel features of malarial AdoMetDC suggest possibilities for the discovery of parasite-specific inhibitors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16257247     DOI: 10.1016/j.jmgm.2005.09.011

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  7 in total

1.  Sub-AQUA: real-value quality assessment of protein structure models.

Authors:  Yifeng David Yang; Preston Spratt; Hao Chen; Changsoon Park; Daisuke Kihara
Journal:  Protein Eng Des Sel       Date:  2010-06-04       Impact factor: 1.650

2.  Low-homology protein threading.

Authors:  Jian Peng; Jinbo Xu
Journal:  Bioinformatics       Date:  2010-06-15       Impact factor: 6.937

Review 3.  Polyamine homoeostasis as a drug target in pathogenic protozoa: peculiarities and possibilities.

Authors:  Lyn-Marie Birkholtz; Marni Williams; Jandeli Niemand; Abraham I Louw; Lo Persson; Olle Heby
Journal:  Biochem J       Date:  2011-09-01       Impact factor: 3.857

Review 4.  Integration and mining of malaria molecular, functional and pharmacological data: how far are we from a chemogenomic knowledge space?

Authors:  Lyn-Marie Birkholtz; Olivier Bastien; Gordon Wells; Delphine Grando; Fourie Joubert; Vinod Kasam; Marc Zimmermann; Philippe Ortet; Nicolas Jacq; Nadia Saïdani; Sylvaine Roy; Martin Hofmann-Apitius; Vincent Breton; Abraham I Louw; Eric Maréchal
Journal:  Malar J       Date:  2006-11-17       Impact factor: 2.979

5.  Deletion mutagenesis of large areas in Plasmodium falciparum genes: a comparative study.

Authors:  Marni Williams; Abraham I Louw; Lyn-Marie Birkholtz
Journal:  Malar J       Date:  2007-05-22       Impact factor: 2.979

6.  Novel S-adenosyl-L-methionine decarboxylase inhibitors as potent antiproliferative agents against intraerythrocytic Plasmodium falciparum parasites.

Authors:  Dina le Roux; Pieter B Burger; Jandeli Niemand; Anne Grobler; Patricia Urbán; Xavier Fernàndez-Busquets; Robert H Barker; Adelfa E Serrano; Abraham I Louw; Lyn-Marie Birkholtz
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2013-12-05       Impact factor: 4.077

7.  Use of a Chimeric Hsp70 to Enhance the Quality of Recombinant Plasmodium falciparum S-Adenosylmethionine Decarboxylase Protein Produced in Escherichia coli.

Authors:  Xolani Henry Makhoba; Adélle Burger; Dina Coertzen; Tawanda Zininga; Lyn-Marie Birkholtz; Addmore Shonhai
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.